Browse recruiting and upcoming clinical trials for tuberous sclerosis complex.
Patient-friendly, AI-assisted summaries based on official ClinicalTrials.gov ↗ records. Last updated: Oct 10, 2026
About this listHide
ClinicalTrials.gov is the complete and most up-to-date source. Trials may be missing, and trial information may have changed since our last check. Always verify important information in the official registry.
Who can join AIPeople with neurodevelopmental disorders and anxiety, including autism, fragile X, tuberous sclerosis, 22q11 deletion, ADHD, and tic/Tourette disorders.
What is being studied AICompares sertraline with placebo for anxiety symptoms in children and adolescents with neurodevelopmental disorders.
Who can join AIInfants (15 months or younger) with a confirmed diagnosis of one of several rare neurogenetic conditions and their parent/primary caregiver (English-speaking household).
What is being studied AITests a parent-focused early intervention (PIXI) for infants diagnosed with rare neurogenetic disorders.
Who can join AIPeople aged 16–30 with chronic kidney disease or related kidney conditions (proteinuria; blood pressure control; CAKUT; nephrotic syndrome; sickle‑cell nephropathy; tuberous sclerosis; cancer survivors).
What is being studied AITests whether a smartphone app improves adherence to KDIGO 2024 CKD guideline recommendations.
Who can join AIAdults with Alport syndrome, Fabry disease, tuberous sclerosis complex, SLE with kidney involvement, non-rare CKD, or people without CKD as controls.
What is being studied AICompares periodontal health in rare kidney diseases, CKD controls, and population controls.
Who can join AIAdults (≥18) with a new or previous clinical diagnosis of any listed neuroendocrine neoplasm or related endocrine tumor or syndrome (e.g., pancreatic/GI NEN, medullary thyroid cancer, paraganglioma/pheochromocytoma, pituitary tumor, MEN syndromes).
What is being studied AICollects genetic and clinical data to find inherited and tumor-specific DNA changes.
Who can join AIPeople with genodermatoses who wish to have children, their partners (if applicable), and healthcare professionals caring for these patients.
What is being studied AICollects one-on-one interviews about reproductive decision-making and counselling views.
Who can join AIPeople with cystic fibrosis, pulmonary fibrosis, tuberous sclerosis, asthma, pulmonary sarcoidosis, other lung diseases, and healthy volunteers.
What is being studied AISurveys genetic variants and gene expression in people with and without lung disease.
Who can join AIPeople with lymphangioleiomyomatosis and related lung conditions, including pneumothorax and tuberous sclerosis–associated lung disease.
What is being studied AICollects clinical data, imaging, and genetic and protein analyses to study LAM disease processes.
Who can join AIPeople or couples with a molecularly confirmed inherited skin disease who considered or had prenatal diagnosis (PND) or preimplantation genetic testing (PGT).
What is being studied AICollects past clinical and reproductive data on prenatal diagnosis and preimplantation genetic testing outcomes.
Trials that may include tuberous sclerosis complex (3)
ClinicalTrials.gov returned these when we searched for this condition, but we could not confirm from the registry records that they are intended for people with it. Check each trial’s eligibility criteria, and ask the study team if you are unsure.
Who can join AIAdults 18–55 with relapsing‑remitting multiple sclerosis (disease duration <15 years) who have acute inflammatory demyelinating brain lesions.
What is being studied AITests whether clemastine changes MRI measures of myelin in acute demyelinating brain lesions.